NCT01486498
Quality of Life and Health Economic Measurements in Allergic Patients Treated With Immunotherapy No drug interventions Not Available Not Available completed NCT01425788
Comparison of Different Up-dosing Schedules With Osiris Phleum Pratense No drug interventions treatment 2 completed NCT01448603
ToleroMune Ragweed Follow up Study No drug interventions Not Available Not Available completed NCT04583202
Evaluation of the Nasal and Conjunctival Response in Subjects Allergic to Birch Pollen in the ALYATEC Environmental Exposure Chamber No drug interventions basic_science Not Available completed NCT01447784
ToleroMune House Dust Mites (HDM) Exposure Chamber Study No drug interventions treatment 2 completed NCT01591343
Safety Study of Depigoid Vaccine Dermatophagoides Pteronyssinus or 50% Dermatophagoides Pteronyssinus / 50% Dermatophagoides Farinae (500 DPP/ml), to Treat Allergic Rhinitis or Rhinoconjunctivitis With or Without Asthma No drug interventions prevention 2 terminated NCT01720251
Efficacy Study of a Preseasonal Treatment With AllerT in Subjects With Birch Pollen Allergy No drug interventions treatment 2 completed NCT03821077
Study to Evaluate the Efficacy and Safety of "Allergovac Poliplus" in Polysensitized Patients With Allergic Rhinitis/Rhinoconjunctivitis, With or Without Asthma No drug interventions Not Available Not Available completed NCT01949428
House Dust Mite Observational Study No drug interventions Not Available Not Available completed NCT06448585
Dietary Supplement (Beta-Glucans) in Allergic Patients Undergoing Subcutaneous Immunotherapy. No drug interventions treatment 4 active_not_recruiting NCT02844842
Evaluation of Tolerability and Safety of "Allergovac Poliplus" in Polysensitized Patients With Rhinitis or Allergic Rhinoconjunctivitis With or Without Asthma: A Study in Daily Clinical Practice No drug interventions Not Available Not Available completed NCT01604018
An Optional Two Year Follow Up Study to Study CP005A No drug interventions Not Available Not Available completed NCT02477917
A Multicenter, Open Trial With Subcutaneous Immunotherapy (SCIT) in Patients With Rhinoconjunctivitis Sensitized to Parietaria Judaica No drug interventions treatment 1 completed NCT05540717
Efficacy and Safety of PQ Grass in Subjects With Seasonal Allergic Rhinitis and/or Rhinoconjunctivitis Induced by Grass Pollen No drug interventions treatment 3 completed NCT02340130
Safety, Tolerability and Efficacy of the Depigmented Modified Allergen Extract of Two Mites in Subjects With Allergic Rhinitis or Rhinoconjunctivitis, With Controlled Allergic Asthma No drug interventions treatment 2 completed NCT01921257
Paediatric Safety Study in Cat-PAD No drug interventions treatment 2 completed NCT05960266
Immunological Analysis of Lymph Node Tissue After Intralymphatic Immunotherapy: A Prospective Case Control Study No drug interventions basic_science 0 active_not_recruiting NCT01734265
Safety Clinical Trial With Depigopid 50% Grasses/50% Olea Europaea(2000DPP/ml) or Depigoid 50% Grasses/50% Parietaria Judaica(2000DPP/ml). No drug interventions treatment 2 completed NCT00540631
Multicenter Trial of Immunotherapy With House Dust Mite Allergoid treatment 3 completed NCT01923792
ToleroMune House Dust Mite Follow on Study No drug interventions Not Available Not Available completed NCT00457444
Study to Assess the Clinical Efficacy and Safety of a Novel Method of Specific Allergen Immunotherapy in Grass Pollen Allergic Subjects by Epicutanous Allergen Administration No drug interventions treatment 1 completed NCT00671268
Evaluation of Safety and Efficacy of Specific Immunotherapy With Recombinant Major Allergens of Timothy Grass Pollen Adsorbed Onto Aluminium-hydroxide in Patients With IgE-mediated Allergic Rhinoconjunctivitis +/- Controlled Asthma No drug interventions treatment 3 completed NCT02849210
A Clinical Trial With Subcutaneous Immunotherapy in Depot Presentation in Patients With Rhinoconjuncitivis Sensitized to Olea Europaea No drug interventions treatment 1 completed NCT00550550
Efficacy and Safety of Grass Sublingual Tablet in Children and Adolescents (P05239 AM3)(COMPLETED) treatment 3 completed NCT01272323
Cat-PAD Follow on Study No drug interventions Not Available Not Available completed NCT02654223
Dose Finding for the Treatment of Rhinitis/Rhinoconjunctivitis Against Grass Pollen Allergy No drug interventions screening 2 completed NCT02075138
Grass Observational Study No drug interventions Not Available Not Available completed NCT02150343
Phase II HDM-SPIRE Safety and Efficacy Study No drug interventions treatment 2 completed NCT04435990
Efficacy and Safety Evaluation for the Treatment of Allergy Against Mites No drug interventions treatment 3 recruiting NCT01923779
ToleroMune Grass Follow on Study No drug interventions Not Available Not Available completed NCT04476433
Intervention in Chronic Pediatric Patients and Their Families. No drug interventions prevention Not Available completed NCT02661854
Dose Finding for the Treatment of Rhinitis/Rhinoconjunctivitis Against Mite Allergy No drug interventions screening 2 unknown_status NCT05560698
A Motivation-enhancing App to Retain Patients With Hay Fever in a Trial After Treatment No drug interventions other Not Available unknown_status NCT04898283
Efficacy and Safety Evaluation of the Treatment of Allergy Against Cupressaceae and Grasses. No drug interventions treatment 3 recruiting NCT01949415
An Optional Investigation of Biomarkers of Efficacy No drug interventions Not Available Not Available completed NCT04891237
Efficacy and Safety Evaluation for the Treatment of Allergy Against Grass and Olive Pollen No drug interventions treatment 3 recruiting NCT00800332
Dose Finding Study With CYT003-QbG10 in Patients With House Dust Mite Allergy treatment 2 completed NCT01385800
ToleroMune Grass Exposure Unit Study No drug interventions treatment 2 completed NCT01013259
Immunomodulation of E.Coli Nissle 1917 in Patients With Grass Pollen Rhinoconjunctivitis No drug interventions treatment 2 completed NCT00562159
Efficacy and Safety of Grass Sublingual Tablet in Adults (P05238 AM3)(COMPLETED) treatment 3 completed NCT02292875
ToleroMune Grass Follow on Study No drug interventions Not Available Not Available completed NCT00537342
Immunotherapy With Depigmented and Polymerized Allergen Extract of Olea Europaea (GPIT) No drug interventions treatment 3 completed NCT01949441
ToleroMune House Dust Mite (HDM) Tolerability Study No drug interventions treatment 2 completed NCT01620762
Phase III Cat-PAD Study No drug interventions treatment 3 completed NCT02396680
Ragweed-SPIRE Follow-On Study No drug interventions Not Available Not Available completed NCT00978029
Safety Study of Ragweed Allergy Immunotherapy Tablet in Subjects 50 Years of Age and Older (Study P06081) No drug interventions treatment 2 completed NCT03414801
Red Maple Trials Cat Allergen Natural Exposure Chamber Validation in Cat-allergic Subjects No drug interventions other Not Available completed NCT01808768
Ocular Allergy Treatment Practical Impact Trial treatment 4 unknown_status NCT00574210
PK/PD and Steady State Efficacy Study of Bilastine Compared With Placebo Given Orally in the Treatment of the Symptoms of SAR in an EEC Model (5-arm) treatment 2 completed NCT00818181
Open Label Safety Study of a Birch Pollen Allergen Extract No drug interventions treatment 2 completed NCT01353755
2nd Pivotal Study rPhleum - Adults and Adolescents With Rhinoconjunctivitis +/-Controlled Asthma No drug interventions treatment 3 completed